Tweet
Vaccine. Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).
[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]
Vaccine. 2014 Apr 29. pii: S0264-410X(14)00598-2. doi: 10.1016/j.vaccine.2014.04.060. [Epub ahead of print]
Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).
Huy CD<SUP>1</SUP>, Sakoda Y<SUP>1</SUP>, Nishi T<SUP>1</SUP>, Hiono T<SUP>1</SUP>, Shichinohe S<SUP>1</SUP>, Okamatsu M<SUP>1</SUP>, Kida H<SUP>2</SUP>.
Author information: <SUP>1</SUP>Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060-0818, Japan. <SUP>2</SUP>Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060-0818, Japan; Research Center for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan. Electronic address: kida@vetmed.hokudai.ac.jp.
Abstract
H7N9 influenza virus infection in humans was reported in China on March 31, 2013. Humans are immunologically na?ve to the H7N9 subtype, for which the seasonal influenza vaccine is not effective. Thus, the development of an H7N9 influenza virus vaccine is an urgent issue. To prepare for the emergence of an influenza pandemic, we have established a library comprising more than 1300 influenza virus strains with 144 different combinations of 16 HA and 9 NA subtypes. An H7N9 virus strain isolated from a 35-year-old woman, A/Anhui/1/2013 (H7N9), was found to be antigenically similar to H7N9 influenza viruses isolated from migratory ducks. In the present study, the potency of an inactivated whole virus particle vaccine prepared from an H7N9 low pathogenic avian influenza virus, A/duck/Mongolia/119/2008 (H7N9), selected from the library, was assessed by a challenge with A/Anhui/1/2013 (H7N9). The results indicate that the test vaccine was potent enough to induce sufficient immunity to reduce the impact of disease caused by the challenge with A/Anhui/1/2013 (H7N9) in mice. The present results indicate that an inactivated whole virus particle vaccine prepared from an influenza virus strain stored in the library could be useful as a vaccine strain in case of an influenza pandemic.
Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS: Antigenicity, H7N9 influenza, Human, Vaccine
PMID: 24793949 [PubMed - as supplied by publisher]
-
------
Vaccine. 2014 Apr 29. pii: S0264-410X(14)00598-2. doi: 10.1016/j.vaccine.2014.04.060. [Epub ahead of print]
Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).
Huy CD<SUP>1</SUP>, Sakoda Y<SUP>1</SUP>, Nishi T<SUP>1</SUP>, Hiono T<SUP>1</SUP>, Shichinohe S<SUP>1</SUP>, Okamatsu M<SUP>1</SUP>, Kida H<SUP>2</SUP>.
Author information: <SUP>1</SUP>Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060-0818, Japan. <SUP>2</SUP>Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060-0818, Japan; Research Center for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan. Electronic address: kida@vetmed.hokudai.ac.jp.
Abstract
H7N9 influenza virus infection in humans was reported in China on March 31, 2013. Humans are immunologically na?ve to the H7N9 subtype, for which the seasonal influenza vaccine is not effective. Thus, the development of an H7N9 influenza virus vaccine is an urgent issue. To prepare for the emergence of an influenza pandemic, we have established a library comprising more than 1300 influenza virus strains with 144 different combinations of 16 HA and 9 NA subtypes. An H7N9 virus strain isolated from a 35-year-old woman, A/Anhui/1/2013 (H7N9), was found to be antigenically similar to H7N9 influenza viruses isolated from migratory ducks. In the present study, the potency of an inactivated whole virus particle vaccine prepared from an H7N9 low pathogenic avian influenza virus, A/duck/Mongolia/119/2008 (H7N9), selected from the library, was assessed by a challenge with A/Anhui/1/2013 (H7N9). The results indicate that the test vaccine was potent enough to induce sufficient immunity to reduce the impact of disease caused by the challenge with A/Anhui/1/2013 (H7N9) in mice. The present results indicate that an inactivated whole virus particle vaccine prepared from an influenza virus strain stored in the library could be useful as a vaccine strain in case of an influenza pandemic.
Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS: Antigenicity, H7N9 influenza, Human, Vaccine
PMID: 24793949 [PubMed - as supplied by publisher]
-
------